Will Herpes Show Up in a Blood Test? What to Know

Herpes simplex virus (HSV) does show up in a blood test, but the results are far less straightforward than most people expect. Blood tests detect antibodies your immune system produces after infection, not the virus itself, and this distinction creates a surprising number of complications. Depending on the test used, the timing, and your individual risk profile, a positive result might not mean what you think it means, and a negative result might not mean you’re in the clear either.

What a Blood Test Actually Detects

When you get a blood test for herpes, the lab is looking for IgG antibodies specific to HSV-1 (which usually causes oral herpes) or HSV-2 (which usually causes genital herpes). These antibodies are proteins your immune system builds over weeks to months after an initial infection, and they remain detectable for life. The test doesn’t find the virus circulating in your blood. Herpes doesn’t typically live in the bloodstream; it hides in nerve cells and only surfaces at the skin or mucous membranes during outbreaks or asymptomatic shedding.

This is an important distinction because it means a blood test tells you whether you’ve been exposed at some point, not whether you currently have an active infection. If you have a sore right now and want to know if it’s herpes, the gold standard is a swab of the lesion tested by PCR (a method that detects viral DNA directly). Blood tests are better suited for answering a different question: have I ever been infected?

Accuracy Varies More Than You’d Think

Not all herpes blood tests perform equally. A 2024 study comparing three widely used automated platforms found that Bio-Rad and Roche assays had high specificity (above 97%) for both HSV-1 and HSV-2 IgG but relatively low sensitivity for HSV-1 (below 85%). The DiaSorin assay had better sensitivity but worse specificity, meaning it caught more true positives but also generated more false positives.¹ Another study comparing immunoblot, ELISA, and chemiluminescent methods found that all three performed well for HSV-2, with sensitivities above 98% and specificities ranging from about 98% to 100%.²

Those numbers sound reassuring, but they don’t tell the whole story. The real trouble starts when you look at what happens at the population level rather than in a controlled lab setting.

The False Positive Problem

The single most important thing to understand about herpes blood tests is that low-positive results are unreliable. The most commonly used screening test in the United States, the HerpeSelect HSV-2 IgG ELISA, reports results as an index value. Anything at or above 1.10 is technically positive. But results in the low-positive range, roughly 1.10 to 3.50, have a false positive rate that can reach 50% in people who are at low risk for HSV-2.³ That means if you’re in a low-risk group and your test comes back at, say, 2.0, there’s essentially a coin flip’s chance that the result is wrong.

The problem extends beyond just the low-positive zone, too. That same study found that among sera confirmed as false positives, about 20% on the HerpeSelect platform actually had index values above 3.50, a range many clinicians consider reliable.³ So even a “solidly positive” result can occasionally be wrong. The 2024 automated testing study underscored this further: based on an estimated U.S. HSV-2 prevalence of about 12%, nearly one in three positive results on the DiaSorin platform would be falsely positive.¹

Why does this happen? Much of it comes down to how prevalence interacts with test performance. Even a highly specific test produces a meaningful number of false positives when the condition being tested for is relatively uncommon in the population being screened. When roughly 12% of people carry HSV-2 antibodies, a test that is 98% specific will still misidentify some uninfected people, and those misidentified individuals can outnumber the true positives in certain clinical settings.

When to Get a Confirmatory Test

CDC guidelines recommend that anyone with a low-positive HSV-2 IgG index (1.10 to 3.50) get confirmatory testing. The traditional gold standard for confirmation is the Western blot, developed at the University of Washington. It’s considerably more accurate than screening ELISAs but also more expensive and harder to access, since only a handful of labs run it. However, as the research on false positives above 3.50 shows, confining confirmatory testing to only low-positive results misses some false positives and can lead to misdiagnosis.³

If you’ve received a positive HSV-2 blood test and have never had symptoms, pushing for a Western blot before accepting the diagnosis is reasonable. This is especially true if your index value was in the low-positive range, if you’re in a low-risk group, or if the diagnosis would cause you significant distress. Many clinicians aren’t aware of how unreliable low-positive results can be, so you may need to advocate for yourself on this point.

The Window Period and When to Test

Timing matters. After a new herpes infection, your body doesn’t produce detectable IgG antibodies overnight. This window period typically lasts several weeks, and for some people it can stretch to three or four months. During that time a blood test will come back negative even though you’re infected. If you think you were recently exposed and want a definitive answer, a single negative blood test taken a week after exposure tells you almost nothing. Most guidelines suggest waiting at least 12 weeks after a possible exposure before relying on a blood test result.

IgM antibodies, which are the body’s first-responder antibodies, appear earlier than IgG and have sometimes been marketed as a way to detect “new” infections. But IgM testing for herpes is widely considered unreliable. IgM antibodies were detected in roughly a third of people with long-established HSV-2 infections in one study, meaning the test frequently lights up in people who were infected years ago, not just in those who are newly exposed.⁴ IgM testing also cross-reacts between HSV-1 and HSV-2, so a positive IgM doesn’t reliably tell you which type you have. Most experts and guidelines advise against using IgM tests for herpes diagnosis.

One nuance worth knowing: early antiviral treatment during a first outbreak can delay how quickly antibodies develop. A classic study found that people treated with acyclovir during their initial genital herpes episode took significantly longer to develop antibodies to certain HSV proteins compared to those given a placebo, with mean seroconversion times roughly doubling for some markers.⁵ If you were treated with antivirals for a suspected first episode, you may need to wait even longer before a blood test will reflect your status.

Why Your Doctor Probably Won’t Offer This Test Routinely

Many people are surprised to learn that herpes testing is not part of a standard STI panel. The U.S. Preventive Services Task Force (USPSTF) has explicitly recommended against routine serologic screening for genital herpes in people without symptoms, including pregnant individuals. Their reasoning is that the potential harms, including false-positive results, unnecessary confirmatory testing, and psychological distress, outweigh the benefits, particularly since screening asymptomatic people hasn’t been shown to improve clinical outcomes.⁶

This recommendation frustrates some people who want comprehensive screening and feel they have a right to know their status. The counterargument from public health authorities is straightforward: given the false positive rates discussed above, routine screening would hand a large number of uninfected people a devastating and incorrect diagnosis. Someone tested in a low-risk population has a meaningful chance of being told they have herpes when they don’t, with all the emotional and relational fallout that follows. Testing is absolutely appropriate when you have symptoms, when a partner has been diagnosed, or when you’re making specific decisions about risk with a new sexual partner. The recommendation against screening applies specifically to the “test everyone just because” approach.

Asymptomatic Infection and What It Means for Transmission

A major reason people seek herpes blood testing is concern about unknowingly transmitting the virus. That concern is well-founded. Most people with HSV-2 don’t know they have it, either because their symptoms are mild enough to go unnoticed or because they’ve never had a recognizable outbreak. Even without symptoms, the virus can still be transmitted.

A study that tracked viral shedding through daily genital swabs found that people with symptomatic HSV-2 shed virus on about 20% of days, while those with asymptomatic infection shed on about 10% of days.⁷ The critical finding was that when shedding did occur in asymptomatic individuals, the amount of virus released was essentially the same as in symptomatic people. In other words, less frequent shedding doesn’t mean less infectious shedding, it just happens on fewer days.

HSV-1, though more commonly thought of as “just cold sores,” also sheds frequently when people are symptom-free. One study tracking healthy adults with HSV-1 found shedding on about 27% of non-lesional days, predominantly from the oral mucosa.⁸ This helps explain why genital HSV-1 infections, acquired through oral-genital contact, have become increasingly common.

Testing During Pregnancy

Herpes testing takes on a different calculus for pregnant people. Neonatal herpes, though rare, is a serious and sometimes fatal condition. The greatest risk occurs when a person acquires a new genital herpes infection close to delivery, because there hasn’t been enough time to develop protective antibodies that would be passed to the baby. A person with a long-standing infection, by contrast, has antibodies circulating that offer the newborn some passive protection.

Despite this clear clinical logic, no major medical organization currently recommends universal HSV screening during pregnancy.⁹ The concern is the same as in the general population: false positives would create anxiety and trigger interventions (like unnecessary cesarean deliveries) in people who aren’t actually infected. Some individual practitioners do offer type-specific serologic testing in pregnancy, particularly when a pregnant person’s partner has known genital herpes. In one study of pregnant women who agreed to be tested, 20% were seropositive for HSV-2 and 60% for HSV-1.¹⁰ Knowing serostatus can help clinicians counsel discordant couples, where one partner carries the virus and the other doesn’t, about precautions during the third trimester.

The Emotional Weight of a Positive Result

The psychological fallout of a herpes diagnosis, especially an unexpected one from a blood test, deserves honest discussion. The stigma around herpes is wildly disproportionate to the medical reality of the infection, which for most people amounts to an occasional nuisance. But that doesn’t mean a positive test result feels like a nuisance.

Research on this has produced somewhat reassuring findings overall. A study that followed people diagnosed with asymptomatic HSV-2 through blood testing found no significant lasting differences in psychological well-being compared to those who tested negative.¹¹ But the same study noted that many HSV-2-positive individuals reported a notable impact on their quality of life, and those who struggled most were people who were already interpersonally vulnerable before the diagnosis, people with lower social support, higher sensitivity to rejection, or less satisfying sexual relationships. A review of the broader literature echoed this pattern: a herpes diagnosis doesn’t typically cause persistent psychological harm, but it often affects people in subtler ways related to self-image and sexual confidence.¹²

This is part of why the USPSTF weighs psychological harm so heavily in its recommendation against routine screening. Giving someone a diagnosis that may be false positive, or that accurately identifies an infection that will never cause symptoms, carries real emotional costs. If you do seek testing and receive a positive result, connecting with accurate information and, if needed, a counselor who understands sexual health can make a meaningful difference in how the diagnosis lands.

Newer Testing Formats

The landscape of herpes testing is slowly evolving. One of the most practical developments is point-of-care testing using a fingerstick blood sample rather than a traditional venous draw. A rapid lateral flow test compared against Western blot in a clinical trial of over 600 participants showed positive predictive agreement above 94% for HSV-1 and 99% for HSV-2 among people seeking STI care.¹³ Performance was somewhat lower in pregnant women but still in a clinically useful range. The appeal of these tests is speed and accessibility: a result in minutes, at the point of care, without a lab requisition or a multiday wait.

Whether point-of-care tests will face the same low-positive-index false positive problems as current ELISAs remains to be fully studied in broader populations. But the move toward faster, more accessible testing is particularly meaningful for settings like sexual health clinics and prenatal visits, where waiting days for a result can complicate decision-making.

HSV-1 Versus HSV-2 in Blood Test Interpretation

Blood tests that distinguish between HSV-1 and HSV-2 are called type-specific, and the distinction matters more than most people realize. Because HSV-1 is extremely common (the majority of adults worldwide carry it, often from childhood exposure), a positive HSV-1 IgG result on its own usually doesn’t tell you much clinically. You likely got it from a kiss as a child and may never have had a recognizable cold sore. A positive HSV-2 result is more clinically significant because HSV-2 is almost always acquired sexually and tends to cause more frequent recurrences genitally.

Here’s where it gets tricky: HSV-1 antibodies can sometimes interfere with HSV-2 testing accuracy. One study of patients with PCR-confirmed genital HSV-2 found that only about 38% tested positive for HSV-2 IgG, while a large proportion tested positive for HSV-1 IgG alone or for both types.¹⁴ This suggests that in real-world clinical settings, relying solely on blood tests can miss a substantial proportion of true HSV-2 infections, particularly in people who also carry HSV-1. If you have recurrent genital symptoms but your HSV-2 blood test is negative, getting a swab-based PCR test during an active episode is the best way to figure out what’s actually going on. Genital HSV-1 infections are increasingly common and won’t be identified by an HSV-2-specific blood test.

When a Blood Test Is and Isn’t the Right Call

Given all the caveats above, you might wonder whether a herpes blood test is ever worth getting. It clearly is in certain situations. If your partner has been diagnosed with genital herpes, a type-specific blood test can tell you whether you already carry the same virus, which changes the risk conversation entirely. If you’ve had recurrent symptoms that look like herpes but never had a lesion swabbed, a positive blood test with a high index value adds supporting evidence. If you’re pregnant and your partner has a known history of genital herpes, knowing your own serostatus helps your obstetrician plan delivery safely.

Where blood testing gets murkier is in the “just want to know” scenario with no symptoms and no known exposure. The test can give you useful information, but it can also give you false information, and distinguishing between the two often requires a confirmatory test that’s expensive and hard to get. If you do choose to test in this situation, going in with your eyes open about the possibility of a false positive, and knowing that a Western blot exists as a backup, puts you in a much better position to handle whatever the result says.

One practical note: many at-home and direct-to-consumer STI test kits now include HSV-2 antibody testing. These use the same ELISA technology as lab-ordered tests and carry the same limitations, including the low-positive false positive problem. The convenience of ordering online doesn’t change the biology. If you use one of these services and receive a positive result in the low-positive index range, the same recommendation applies: seek a confirmatory test before treating the result as definitive.